The following sections were updated in follow-up.The device was used in treatment and not returned for analysis.There was no specific performance related failure reported by the user.According to the user, transseptal puncture and sheath positioning into the la might determine coronary spasm and transient st elevation.The device history records were reviewed to confirm that the device passed all applicable in-process and final inspections.No further investigation is required based on the investigation, a capa is not required.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|